Show simple item record

dc.contributor.authorEggleton, Pen_GB
dc.contributor.authorBremer, Een_GB
dc.contributor.authorTarr, J.M.en_GB
dc.contributor.authorde Bruyn, Men_GB
dc.contributor.authorHelfrich, Wen_GB
dc.contributor.authorKendall, Aen_GB
dc.contributor.authorHaigh, Richarden_GB
dc.contributor.authorViner, N.J.en_GB
dc.contributor.authorWinyard, Paul G.en_GB
dc.date.accessioned2012-12-14T14:13:20Zen_GB
dc.date.accessioned2013-03-20T17:10:43Z
dc.date.issued2011-12-15en_GB
dc.description.abstractRheumatoid arthritis (RA) is considered a T cell driven autoimmune disease, therefore, the ability of B cell depleting biologics, e.g., anti-CD20 antibodies, to alleviate RA is unclear. This study examined the proportions of IL-17-secreting lymphocytes in the blood of healthy subjects and RA patients and determined if Th17 cells belong to a CD20+ subset of T cells.en_GB
dc.identifier.citationVol. 13, Issue 6, article R208en_GB
dc.identifier.doi10.1186/ar3541en_GB
dc.identifier.urihttp://hdl.handle.net/10036/4086en_GB
dc.publisherBMC
dc.titleFrequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjectsen_GB
dc.typeArticle
dc.date.available2012-12-14T14:13:20Zen_GB
dc.date.available2013-03-20T17:10:43Z
exeter.place-of-publicationEnglanden_GB
dc.identifier.journalArthritis Research and Therapyen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record